Literature DB >> 8841992

Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains.

G A Elder1, N Tezapsidis, J Carter, J Shioi, C Bouras, H C Li, J M Johnston, S Efthimiopoulos, V L Friedrich, N K Robakis.   

Abstract

Many individuals with familial Alzheimer disease (FAD) have mutations in a gene termed S182 or presenilin I (PS-I). Currently, the PS-I gene product has not been identified and its function remains unknown. Here we report that affinity purified antibodies against the predicted amino acid sequence of the PS-I gene product detected in homogenates of human, mouse, and rat brains a single antigen of approximately 48 kDa. This antigen was also present in immortalized human and mouse neuronal cell cultures. Brain tissue fractionation showed that all PS-I antigen was found in the membrane fraction. In stained tissue sections of mouse central nervous system (CNS), PS-I antigen was found only in neurons throughout brain and spinal cord and was located within cell bodies, axons, and dendrites. Remarkably the relative partition among these three compartments varied dramatically. A striking feature of PS-I expression was its intense concentration in some (but not all) dendrites, at levels substantially above those in the parent perikarya. In most of the cerebrum, PS-I staining in axons was very weak or undetectable. By contrast, many axons in portions of the brainstem and in the spinal cord showed marked PS-I immunoreactivity. Similarly, staining of sections from human temporal cortex showed that PS-I was present mainly in neuronal cell bodies and dendrites. These data show that in the CNS, PS-I is expressed mainly in neurons and suggests that this protein may perform a neuron specific function. The pattern of PS-I expression in the CNS would suggest that the premature neurodegeneration associated with PS-I mutations involves a primary neuronal process rather than a secondary effect of PS-I produced in non-neuronal cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841992     DOI: 10.1002/(SICI)1097-4547(19960801)45:3<308::AID-JNR13>3.0.CO;2-#

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  29 in total

Review 1.  Presenilins: structural aspects and posttranslational events.

Authors:  F Checler
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex.

Authors:  L Baki; P Marambaud; S Efthimiopoulos; A Georgakopoulos; P Wen; W Cui; J Shioi; E Koo; M Ozawa; V L Friedrich; N K Robakis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.

Authors:  D M Mann; S M Pickering-Brown; A Takeuchi; T Iwatsubo
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

4.  Presenilin-1 is associated with Alzheimer's disease amyloid.

Authors:  T Wisniewski; W K Dowjat; B Permanne; J Palha; A Kumar; G Gallo; B Frangione
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

5.  Cellular distribution of gamma-secretase subunit nicastrin in the developing and adult rat brains.

Authors:  A Kodam; K S Vetrivel; G Thinakaran; S Kar
Journal:  Neurobiol Aging       Date:  2007-01-12       Impact factor: 4.673

6.  Presenilin-1-immunoreactive neurons are preserved in late-onset Alzheimer's disease.

Authors:  P Giannakopoulos; C Bouras; E Kövari; J Shioi; N Tezapsidis; P R Hof; N K Robakis
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

7.  Light and electron microscopic localization of presenilin-1 in primate brain.

Authors:  J J Lah; C J Heilman; N R Nash; H D Rees; H Yi; S E Counts; A I Levey
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

8.  Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Anne B Rocher; Athena Ching-Jung Wang; William G M Janssen; Tony Flores; Gissel M Perez; James Schmeidler; Dara L Dickstein; Patrick R Hof; Gregory A Elder
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

9.  Selective expression of presenilin 1 in neural progenitor cells rescues the cerebral hemorrhages and cortical lamination defects in presenilin 1-null mutant mice.

Authors:  Paul H Wen; Rita De Gasperi; Miguel A Gama Sosa; Anne B Rocher; Victor L Friedrich; Patrick R Hof; Gregory A Elder
Journal:  Development       Date:  2005-08-03       Impact factor: 6.868

10.  Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis.

Authors:  S Bursztajn; R DeSouza; D L McPhie; S A Berman; J Shioi; N K Robakis; R L Neve
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.